Aedifica enters into one of the Europe’s biggest markets, United Kingdom after completing its previously announced buyout of a leading UK healthcare real estate portfolio for roughly £450m.
The Aedifica’s portfolio in UK has 92 healthcare properties across 90 sites, accounting to an over-all capacity of over 5,700 residents. Most of these care homes have been built purposely, and encompass 100 % single bedroom ratio, with care quality ratings fairly surpassing the market average.
The portfolio is brimming with superb geographical diversifications, being scatter across different parts of the United Kingdom. The portfolio exhibits a potential for further renovation via continuing and identified expansion related and up-gradation projects.
The growing health awareness has led to increase in adoption rate of customized medicines and home diagnostics among consumers. Sensing the end-user demand and requirements players in the home diagnostics market have been focusing on improving accuracy, dependability, convenience and efficiency. A recent study opined that the home diagnostics market will surpass US$ 6.3 million by the end of 2026.
The Aedifica UK portfolio is a hub of highly varied tenant base of 14 well-established operators. The leases falling in this portfolio include inflation-associated triple net leases with a weighted average unexpired lease terms of over two decades. The initial gross yield is nearly 7%.
Aedifica is planning to control and increase its UK portfolio foot hold with the help of Layland Walker that has been offering all kinds of portfolio management services for the respective portfolio for over half a decade now. Layland Walker will provide its support and services to Aedifica exclusively.
The Layland Walker team has seven richly experienced professionals, who have been working on this portfolio for time now and are focused on maintaining long lasting working relationships with the portfolio tenants and the UK healthcare market.
This transaction has been financially backed by the prevailing and fresh debt facilities. The buyout has increased the debt-to-assets ratio of Aedifica by approx. 10% age points.
Mr. Shambhu Nath Jha is a seasoned consultant and researcher. His research papers have been published in reputed websites and trade journals. His interests include philosophy and history.